申请人:University of Georgia Research Foundation, Inc.
公开号:EP1327637A1
公开(公告)日:2003-07-16
The present invention relates to a novel and improved process for preparing 2'-fluoro-5-methyl-β-L-arabinofuranosyluridine represented by formula (1) which shows anti-viral activity, especially potent anti-viral activity against hepatitis B-virus and Epstein-Barr virus.
本发明涉及一种制备式(1)代表的 2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿苷的新型改进工艺,该工艺具有抗病毒活性,特别是对乙型肝炎病毒和 Epstein-Barr 病毒具有强效的抗病毒活性。